Liminal BioSciences - ADR Financials

$8.50

$0.00 (0.00%)

As on 26-Sep-2023 09:30EDT

Market cap

$28 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.4

Div. Yield

0 %

Annual
Quarterly

Cashflow (CA$ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-31.82	-99.60	-75.92	-99.39	-82.45
Cash Flow from Investing Activities	--	--	170.69	2.31	36.10	-5.86
Cash from Financing Activities	--	-45.45	-8.42	57.41	117.92	72.16
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS (CA$)	0.11	-9.32	-14.63	-44.64	-100.13	-2,350.97
Cash EPS (CA$)	--	-8.96	-13.22	-41.55	-95.90	-2,285.29
Adjusted Book Value (CA$)	--	11.67	13.84	8.44	43.69	--
Dividend per Share (CA$)	--	--	--	--	--	--
Cash Flow per Share (CA$)	--	-10.25	-32.33	-27.75	-42.49	-992.23
Free Cash Flow per Share (CA$)	--	-10.26	-32.48	-28.49	-44.39	-1,053.94

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-40.98	-44.95	-99.16	-207.14	-134.15
ROE (%)	-2.15	-73.35	-137.10	-194.97	-1,027.64	-597.63
ROA (%)	0.51	-32.76	-36.96	-86.35	-174.80	-101.03
EBIT Margin (%)	-6,946.95	-8,223.19	-7,707.15	-2,842.12	-4,295.07	-239.67
Net Margin (%)	71.95	-7,210.97	-7,008.24	-3,682.15	-4,776.18	-412.39
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	-12.92	-0.38	-0.81	-0.32	-0.90	0.21
EBIT Growth (%)	19.52	33.46	47.43	55.24	-85.51	7.72
Net Profit Growth (%)	-101.20	35.83	63.10	47.85	-19.89	-78.04
EPS Growth (%)	-99.35	0.36	0.67	0.55	0.96	-1.48
Book Value Growth (%)	-21.22	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	0.04	1.43	3.20	0.46	-2.36
Short term debt to equity ratio	0.03	0.02	0.17	0.30	0.08	-0.16
Current Ratio	2.78	4.09	6.20	3.07	3.03	1.14
Quick Ratio	2.78	--	6.20	2.68	2.79	0.81
Interest Coverage	-19.60	-30.59	-7.83	-10.81	-14.99	-5.08

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	160.16	293.52	166.10	117.67	271.21	42.16
Asset Turnover	0.01	0.00	0.01	0.02	0.04	0.24
Receivable days	--	1,022.43	1,411.86	947.15	1,239.09	119.23
Inventory Days	--	--	--	1,518.94	1,292.85	230.87
Payable days	--	--	--	1,765.08	2,088.19	194.29
Cash Conversion Cycle	--	--	--	701.02	443.75	155.80

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.